Home » Topics » Collaboration, BioWorld Science

Collaboration, BioWorld Science
RSS

Qualigen to develop G4-selective transcription inhibitor from UCL for cancer

Jan. 25, 2022

Alpha Tau enters sponsored research agreement with MD Anderson to study Alpha DaRT in breast cancer

Jan. 21, 2022

Almirall and IRB Barcelona collaborate on molecular glue degraders for skin diseases

Jan. 19, 2022

Evotec and Lilly collaborate on drug discovery for metabolic diseases

Jan. 19, 2022

Eisbach Bio and MD Anderson partner to target synthetic lethality in cancer

Jan. 19, 2022

4basebio and eTheRNA collaborate to evaluate linear DNA for mRNA production

Jan. 18, 2022

Ono and Neurimmune expand drug discovery collaboration for neurodegenerative diseases

Jan. 18, 2022

Vir expands partnership with Gates Foundation in HIV and malaria

Jan. 17, 2022

AstraZeneca and Scorpion collaborate on therapeutics against transcription factors for cancer

Jan. 17, 2022

Everest Medicines licenses global rights to EDDC's 3CL protease inhibitors to treat COVID-19

Jan. 14, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...